查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1696202

全球神經血管支架市場 - 2025 至 2033 年

Global Neurovascular Stents Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球神經血管支架市場規模達到 12.5175 億美元，預計到 2033 年將達到 30.4053 億美元，2025-2033 年預測期內的複合年成長率為 10.4%。

神經血管支架是植入腦血管內的小型網狀管狀裝置，用於治療各種神經血管疾病。它們透過強化衰弱或狹窄的動脈來幫助恢復正常血流，從而降低中風和動脈瘤破裂的風險。這些支架有不同的類型，包括用於打通阻塞腦動脈的顱內支架、用於大頸或寬頸動脈瘤的血流分流器、用於清除急性缺血性中風血栓的支架取栓器，以及用於預防頸動脈狹窄引起中風的頸動脈支架。

市場動態：

促進因素與約束因素

神經血管疾病盛行率上升

中風、動脈瘤和頸動脈疾病等神經血管疾病的發生率不斷上升，大大推動了神經血管支架市場的成長。隨著全球人口老化，這些疾病的發生率正在增加，特別是在更容易患腦血管疾病的老年人身上。

缺血性中風是由於腦血流受阻而導致的，其發生率日益上升，對神經血管支架的需求也隨之增加，神經血管支架作為恢復腦血流和防止進一步損害的治療選擇。例如，根據美國國立衛生研究院 2025 年的報告，研究人員估計美國約有 795,000 人患有中風，其中約 61 萬人是首次發病。幾乎四分之一的中風倖存者在其一生中會再次遭受中風。缺血性中風是由於腦血流受阻而發生的，約佔所有中風病例的 87%。顱內挽救支架（RS）是機械血栓切除術（MT）失敗後治療急性缺血性中風的一種選擇。缺血性中風患者數量的增加增加了神經血管支架手術的需求。

此外，患有顱內動脈粥樣硬化和顱內動脈瘤的患者數量不斷增加，也推動了用於加強脆弱血管、降低破裂風險的支架的應用。

神經血管支架手術費用高昂

神經血管支架手術的高成本是市場成長的重大障礙，特別是在醫療預算和保險覆蓋有限的發展中地區。神經血管支架以及所需的影像、手術專業知識和術後護理使得整體治療費用昂貴，手術費用因複雜性和位置而異。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按類型分類的程式碼片段
  • 材料片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 神經血管疾病盛行率上升
      • 支架技術的進步
    • 限制
      • 神經血管支架手術費用高昂
      • 嚴格的法規核准流程
    • 機會
      • 微創手術需求不斷成長
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 5 章：神經血管支架市場（按類型）

  • 顱內支架
  • 頸動脈支架

第 6 章：神經血管支架市場（按材料）

  • 聚合物
  • 金屬
  • 其他

第 7 章：神經血管支架市場（按應用）

  • 頸動脈狹窄
  • 腦動脈瘤
  • 動靜脈畸形和瘻管
  • 其他

第 8 章：神經血管支架市場（依最終用戶分類）

  • 醫院
  • 門診手術中心
  • 專科診所

第 9 章：神經血管支架市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 11 章：公司簡介

  • Stryker
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Acandis GmbH
  • Balt Group
  • Boston Scientific Corporation
  • Terumo Corporation
  • MicroPort Scientific Corporation

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MD9362

The global neurovascular stents market reached US$ 1,251.75 million in 2024 and is expected to reach US$ 3,040.53 million by 2033, growing at a CAGR of 10.4% during the forecast period 2025-2033.

Neurovascular stents are small, mesh-like tubular devices implanted within brain blood vessels to treat various neurovascular conditions. They help restore normal blood flow by reinforcing weakened or narrowed arteries, reducing the risk of strokes and aneurysm ruptures. These stents come in different types, including intracranial stents for opening blocked brain arteries, flow diverters for large or wide-necked aneurysms, stent retrievers for removing blood clots in acute ischemic stroke, and carotid stents for preventing strokes caused by carotid artery stenosis.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Neurovascular Disorders

The rising prevalence of neurovascular disorders, such as stroke, aneurysms, and carotid artery disease, is significantly driving the growth of the neurovascular stents market. As the global population ages, the incidence of these conditions is increasing, particularly among older adults who are more vulnerable to cerebrovascular diseases.

The growing burden of ischemic strokes, which occur when blood flow to the brain is blocked, has led to a higher demand for neurovascular stents as a treatment option to restore blood flow and prevent further damage. For instance, according to a report by the National Institute of Health in 2025, it is stated that researchers estimate that approximately 795,000 people in the United States experience a stroke, with around 610,000 being first-time occurrences. Nearly 1 in 4 stroke survivors will suffer another stroke in their lifetime. Ischemic strokes, which occur due to blocked blood flow to the brain, account for about 87% of all stroke cases. Intracranial rescue stenting (RS) is an option for acute ischemic stroke after the failure of mechanical thrombectomy (MT). This increasing number of individuals with ischemic stroke individuals increases the need for neurovascular stenting procedures.

Additionally, the increasing number of patients suffering from intracranial atherosclerosis and intracranial aneurysms is fueling the adoption of stents designed to strengthen weakened blood vessels and reduce the risk of rupture.

High Cost of Neurovascular Stent Procedures

The high cost of neurovascular stent procedures is a significant barrier to market growth, particularly in developing regions where healthcare budgets and insurance coverage are limited. Neurovascular stents, along with the required imaging, surgical expertise, and post-procedure care, make the overall treatment expensive and the cost of the procedures varies depending on the complexity and location.

Segment Analysis

The global neurovascular stents market is segmented based on the type, material, application, end-user, and region.

Intracranial stents in the type segment is expected to dominate the neurovascular stents market

The intracranial stent segment is expected to dominate the global neurovascular stents market due to the rising incidence of ischemic strokes, intracranial atherosclerosis, and wide-necked aneurysms. As more patients suffer from cerebrovascular diseases, the demand for minimally invasive stenting solutions continues to grow. Intracranial stents provide a lifesaving alternative to traditional open surgeries, reducing recovery time and improving patient outcomes.

Technological advancements, such as drug-eluting and bioresorbable stents, are also driving adoption, as they help prevent complications like restenosis. Rising number of launches across various regions is expected to drive the segment's growth as these stents will be available for a vast range of individuals. For instance, in June 2024, MicroVention, Inc. announced the commercial launch of the LVIS EVO Intraluminal Support Device in the United States for the treatment of wide-neck intracranial aneurysms. The LVIS EVO, which has been available in Europe since 2019, has already seen over 12,000 units sold. Notably, it is the first fully visible coil-assist intracranial stent introduced to the U.S. market, marking a significant advancement in neurovascular treatment. Additionally, the aging global population is contributing to increased demand, as older adults are more susceptible to neurovascular conditions requiring stent placement.

Geographical Analysis

North America is expected to dominate the neurovascular stents market

North America is expected to dominate the global neurovascular stents market due to several key factors. The region has a high prevalence of neurovascular diseases, including stroke, aneurysms, and intracranial atherosclerosis, driving demand for advanced treatment options like neurovascular stents. For instance, according to the Brain Aneurysm Foundation, with approximately 1 in 50 people in the United States affected by brain aneurysms and an estimated 6.7 million Americans living with an unruptured aneurysm, the demand for neurovascular stents continues to rise, as around 30,000 individuals suffer a rupture each year, increasing the need for advanced neurovascular interventions to prevent life-threatening complications and driving the neurovascular stents market in North America.

The aging population further contributes to this demand, as older adults are at a higher risk of cerebrovascular conditions. The presence of leading medical device companies ensures continuous innovation and a strong pipeline of technologically advanced stents, including drug-eluting and bioresorbable stents. Additionally, well-established healthcare infrastructure, including specialized neurology centers and stroke care units, supports faster adoption of neurovascular stents in hospitals and clinics.

Competitive Landscape

The global market players in the neurovascular stents market are Stryker, Acandis GmbH, Balt Group, Boston Scientific Corporation, Terumo Corporation and MicroPort Scientific Corporation among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global neurovascular stents market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Neurovascular Disorders
      • 3.1.1.2. Advancements in Stent Technology
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Neurovascular Stent Procedures
      • 3.1.2.2. Stringent Regulatory Approval Processes
    • 3.1.3. Opportunity
      • 3.1.3.1. Rising Demand for Minimally Invasive Procedures
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Neurovascular Stents Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Intracranial Stents*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Carotid Artery Stents

6. Neurovascular Stents Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material
  • 6.2. Polymers*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Metal
  • 6.4. Others

7. Neurovascular Stents Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Carotid Artery Stenosis*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cerebral Aneurysms
  • 7.4. Arteriovenous Malformations and Fistulas
  • 7.5. Others

8. Neurovascular Stents Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Specialty Clinics

9. Neurovascular Stents Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Stryker*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Acandis GmbH
  • 11.3. Balt Group
  • 11.4. Boston Scientific Corporation
  • 11.5. Terumo Corporation
  • 11.6. MicroPort Scientific Corporation

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us